Although some reports have been published on the protective effect of antibodies to Toxoplasma gondii surface membrane proteins, few address the inhibitory activity of antibodies to dense granular proteins (GRA proteins). Therefore, we performed a series of experiments to evaluate the inhibitory effects of monoclonal antibodies (mAbs) to GRA proteins (GRA2, 28 kDa; GRA6, 32 kDa) and surface membrane protein (SAG1, 30 kDa) on the invasion of T. gondii tachyzoites. Passive immunization of mice with one of three mAbs following challenge with a lethal dose of tachyzoites significantly increased survival compared with results for mice treated with control ascites. The survival times of mice challenged with tachyzoites pretreated with anti-GRA6 or anti-SAG1 mAb were significantly increased. Mice that received tachyzoites pretreated with both mAb and complement had longer survival times than those that received tachyzoites pretreated with mAb alone. Invasion of tachyzoites into fibroblasts and macrophages was significantly inhibited in the anti-GRA2, anti-GRA6 or anti-SAG1 mAb pretreated group. Pretreatment with mAb and complement inhibited invasion of tachyzoites in both fibroblasts and macrophages. These results suggest that specific antibodies to dense-granule molecules may be useful for controlling infection with T. gondii.
Citations
Citations to this article as recorded by
Different kinetics of humoral response against individual antigens in the ovine model of Toxoplasma gondii infection and its pathological association Paula Formigo, Ignacio Gual, Germán J. Cantón, Luisa F. Mendoza Morales, Emiliano Sosa, Agustina Soto Cabrera, Valeria Scioli, Claudia Morsella, Valeria A. Sander, Dadin P. Moore, Sergio O. Angel, Lucía M. Campero, Marina Clemente Frontiers in Immunology.2025;[Epub] CrossRef
Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infection Mohammad Mahdi Jafari, Zahra Azimzadeh Tabrizi, Mohammad Saaid Dayer, Nazanin Atieh Kazemi-Sefat, Mahshid Mohtashamifard, Rahimeh Mohseni, Atefeh Bagheri, Saeed Bahadory, Amir Karimipour-Saryazdi, Fatemeh Ghaffarifar International Immunopharmacology.2023; 124: 110872. CrossRef
A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis Xiaowei Tian, Hanqi Sun, Meng Wang, Guangmin Wan, Tong Xie, Xuefang Mei, Zhenchao Zhang, Xiangrui Li, Shuai Wang Frontiers in Veterinary Science.2022;[Epub] CrossRef
Control of human toxoplasmosis Nicholas C. Smith, Cibelly Goulart, Jenni A. Hayward, Andreas Kupz, Catherine M. Miller, Giel G. van Dooren International Journal for Parasitology.2021; 51(2-3): 95. CrossRef
Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital Toxoplasmosis Anne di Tommaso, Matthieu O Juste, Zineb Lakhrif, Marie-Noëlle Mévélec, Coraline Borowczyk, Pierre Hammeni, Guillaume Désoubeaux, Nathalie Van Langendonck, Françoise Debierre-Grockiego, Nicolas Aubrey, Isabelle Dimier-Poisson The Journal of Infectious Diseases.2021; 224(4): 705. CrossRef
Treatment of toxoplasmosis: Current options and future perspectives Neda Konstantinovic, Hélène Guegan, Tijana Stäjner, Sorya Belaz, Florence Robert-Gangneux Food and Waterborne Parasitology.2019; 15: e00036. CrossRef
Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity Marijo S. Roiko, Kaice LaFavers, Diane Leland, Gustavo Arrizabalaga International Journal for Parasitology.2018; 48(3-4): 225. CrossRef
Interferon-γ-dependent protection against Neospora caninum infection conferred by mucosal immunization in IL-12/IL-23 p40-deficient mice Pedro Ferreirinha, Ricardo Fróis-Martins, Luzia Teixeira, António Rocha, Manuel Vilanova, Alexandra Correia Vaccine.2018; 36(32): 4890. CrossRef
Plant-derived chimeric antibodies inhibit the invasion of human fibroblasts byToxoplasma gondii Sherene Swee Yin Lim, Kek Heng Chua, Greta Nölke, Holger Spiegel, Wai Leong Goh, Sek Chuen Chow, Boon Pin Kee, Rainer Fischer, Stefan Schillberg, Rofina Yasmin Othman PeerJ.2018; 6: e5780. CrossRef
Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis Shuai Wang, Zhenchao Zhang, Yujian Wang, Javaid A. Gadahi, Lixin Xu, Ruofeng Yan, Xiaokai Song, Xiangrui Li Frontiers in Microbiology.2017;[Epub] CrossRef
Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice Xiao T. Ching, Mun Y. Fong, Yee L. Lau Frontiers in Microbiology.2016;[Epub] CrossRef
Recent Advances in Toxoplasma gondii Immunotherapeutics Sherene Swee-Yin Lim, Rofina Yasmin Othman The Korean Journal of Parasitology.2014; 52(6): 581. CrossRef
Generation of a Neutralizing Human Monoclonal Antibody Fab Fragment to Surface Antigen 1 ofToxoplasma gondiiTachyzoites Yong-Feng Fu, Meng Feng, Kenji Ohnishi, Tamon Kimura, Johbu Itoh, Xun-Jia Cheng, Hiroshi Tachibana, J. H. Adams Infection and Immunity.2011; 79(1): 512. CrossRef
GRA Proteins of Toxoplasma gondii: Maintenance of Host-Parasite Interactions across the Parasitophorous Vacuolar Membrane Ho-Woo Nam The Korean Journal of Parasitology.2009; 47(Suppl): S29. CrossRef
Protective Th1 immune responses against chronic toxoplasmosis induced by a protein–protein vaccine combination but not by its DNA–protein counterpart E. Jongert, D. Verhelst, M. Abady, E. Petersen, N. Gargano Vaccine.2008; 26(41): 5289. CrossRef
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice Majid Golkar, Mohammad-Ali Shokrgozar, Sima Rafati, Karine Musset, Mehdi Assmar, Reza Sadaie, Marie-France Cesbron-Delauw, Corinne Mercier Vaccine.2007; 25(21): 4301. CrossRef
First
Prev
